Dr Cecilia Domínguez Conde
Cecilia joined the Teichmann lab in 2019 to study human immunity across lymphoid and non-lymphoid tissues and to unravel the clonal distributions of T and B lymphocytes.
After completing a degree in Pharmacy in the University of Seville, Cecilia went on to study an MSc in Molecular Medicine at University College London and a PhD in Immunology at the Research Centre for Molecular Medicine of the Austrian Academy of Sciences. Her PhD work focused on dissecting the genetic cause of molecularly undiagnosed primary immunodeficiencies, which led to the discovery of human DOCK2 and POLD immunodeficiencies.
Wellcome Sanger Institute